November 19, 2014
Balaji Sridhar is a CU Boulder Chemical Engineering PhD candidate halfway through two years of the Medical Scientist Training Program, a joint effort between CU campuses in Denver and Boulder. After receiving his PhD degree, he will head back to medical school. He is also leading a company that aims to save millions around the world who die from vaccine-preventable diseases.
March 22, 2013
An advanced polymer technology developed by a team led by ChBE Distinguished Professor Christopher Bowman was recently licensed to 3M, a diversified technology company based in St. Paul, Minn. The licensed technology enables formation of very low-shrinkage composites, improving performance of many materials currently used in dental fillings and sealants, dentures and dental implants.
November 16, 2012
BaroFold Inc., a pharmaceutical company focused on the patented Pressure Enabled Protein Manufacturing (PreEMT) technology invented in the labs of ChBE Professor Theodore Randolph and Dr. John Carpenter, has recently licensed its technology to both Boehringer Ingelheim and Nuron Biotech. Read more about these collaborative efforts below:
October 31, 2012
Ten active companies have been created since 1997 based on technologies invented wholly or in part by CU chemical and biological engineering students and their faculty supervisors. Chemical and biological engineering spinoff companies from CU-Boulder have raised nearly $410 million in follow-on funding, including grants, venture capital financing, U.S. Small Business Administration funding, and acquisitions, according to CU's Technology Transfer Office.
September 28, 2012
Recognizing the revenue potential of CU-licensed science moving to the commercial market, CU is looking at how to best maximize proceeds from technology transfer. The university plans to soon seek bids from consultants to help with this process. A 2012 article in Boulder’s Daily Camera discussed the potential of the JSCBB to result in new commercial compa
June 7, 2012
Christopher Bowman was one of ten to receive a 2012 Tech Commercialization Grant from the state of Colorado for developing inexpensive, highly-efficient synthetic nucleic acids for use in nano-assembly, bio-detection and other bio-functional applications.
January 17, 2012
OPX Biotechnologies was recognized as Bioscience Company of the Year in 2012 by the University of Colorado’s Technology Transfer Office. OPXBIO (Boulder, CO) is a venture-backed company making renewable bio-based chemicals and fuels that are lower cost, higher return and more sustainable than existing petr